Journalism of Courage
Ranbaxy Laboratories
Follow on:
Ranbaxy Laboratories Limited: A Legacy of Pharmaceuticals Ranbaxy Laboratories Limited, an Indian multinational pharmaceutical company, operated from 1961 to 2014. Its history is marked by significant transitions and ultimately, acquisition. Going public in 1973, Ranbaxy experienced two major owners...
Image Source : Wikipedia
- Company type Subsidiary
- Industry Pharmaceuticals
- Founded 1961
- Founders Ranbir Singh, Gurbax Singh
- Headquarters Gurgaon, Haryana, India
- Number of employees 10,983 <small>(2012)</small>
- Parent Sun Pharmaceuticals
Related Other Pages:
- Berkshire Hathaway, MyGate and Motherson Sumi Systems
Ranbaxy Laboratories history
Last Updated : 25/03/25, 11:15 PM
Ranbaxy: A Pharmaceutical Pioneer Founded in 1937 by Ranbir Singh and Gurbax Singh as a Shionogi distributor, Ranbaxy's name reflects its founders. Bhai Mohan Singh acquired the company in 1952, and its expansion accelerated after Parvinder Singh joined in 1967. By 2005, Ranbaxy achieved US$1.178 bi...
RANBAXY LABORATORIES NEWS
Sun Pharma to take ‘appropriate’ action as Ranbaxy deal stalled
May 04, 2014 2:41 am
The Andhra Pradesh High Court had issued orders to stock exchanges BSE and NSE to maintain interim status quo on the matter.
Sun Pharmaceuticals to take 'appropriate action', after $4 bn Ranbaxy Laboratories deal stalled by AP High Court
May 04, 2014 12:01 am
Court has issued orders to maintain status quo on Sun Pharma, Ranbaxy Laboratories deal.
Ranbaxy Laboratories recalls nearly 30,000 packs of allergy-relief drug in US
May 02, 2014 7:48 pm
Tablets being recalled were manufactured by Ranbaxy Laboratories' plant in US.
‘The DNA of Ranbaxy lives on... We have a perfect fit’
April 10, 2014 1:17 am
Israel Makov’s tenure as chairman of Sun Pharmaceutical Industries has seen three acquisitions — URL Pharma, Dusa Pharmaceutical and now Ranbaxy Laboratories.
Sun Pharma is fifth global generics giant with Ranbaxy buy
April 08, 2014 7:20 am
Daiichi Sankyo subsidiary to be acquired for $3.2 billion in stock.
Ranbaxy Laboratories sale shows risk in Japanese M and A adventures
April 07, 2014 2:23 pm
Daiichi Sankyo is handing control of its ailing Ranbaxy to local rival Sun Pharmaceutical in $3.2 billion deal.
Sun Pharmaceuticals to buy beleaguered Ranbaxy Laboratories in $3.2 bn Daiichi Sankyo deal
July 07, 2020 7:18 pm
After facing a host of setbacks, Daiichi Sankyo sells off Ranbaxy Laboratories.
Sun Pharma shares gain more than 4% intraday after announcing plans to acquire Ranbaxy Laboratories
July 06, 2020 8:36 pm
Sun Pharma scrip was trading 1.43 % higher at Rs 580.10, while shares of Ranbaxy Laboratories were trading 5.14% lower at Rs 436.
SC notice to Centre, Ranbaxy on plea for cancelling its licence
March 15, 2014 2:40 am
Ranbaxy insisted drugs sold by it in the Indian market are safe and effective and the company complies with country’s regulations.
Ranbaxy recalls few batches of generic Lipitor tablets in US
March 09, 2014 2:12 am
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs to the United States.
